Results
1
Undervalued Small Caps
1 companies
Newron Pharmaceuticals
Market Cap: CHF 398.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 19.90
7D
4.2%
1Y
96.6%
